10:09 EDT Abivax (ABVX) says ‘we deny the rumors’ to Bloomberg after takeover report
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX:
- Abivax jumps 15% to $129.11 after report of exclusivity with AstraZeneca
- AstraZeneca granted exclusive period by Abivax for buyout, La Lettre reports
- Abivax management to meet with Citizens
- Buy Rating Underpinned by Obefazimod’s Differentiated IBD Profile, Oral Convenience, and Upcoming ABTECT & ENHANCE-CD Data Catalysts
- Qualcomm, Booking Holdings upgraded: Wall Street’s top analyst calls